Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 8
2005 4
2006 7
2007 8
2008 8
2009 2
2010 4
2011 7
2012 6
2013 9
2014 14
2015 16
2016 7
2017 3
2018 7
2019 7
2020 5
2021 6
2022 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Predictive factors for the efficacy of abiraterone acetate therapy in high-risk metastatic hormone-sensitive prostate cancer patients.
Ueda T, Fujita K, Nishimoto M, Shiraishi T, Miyashita M, Kayukawa N, Nakamura Y, Sako S, Ogura R, Fujihara A, Minami T, Hongo F, Okihara K, Yoshimura K, Uemura H, Ukimura O. Ueda T, et al. Among authors: okihara k. World J Urol. 2022 Dec;40(12):2939-2946. doi: 10.1007/s00345-022-04200-2. Epub 2022 Nov 4. World J Urol. 2022. PMID: 36331614
Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b-4 and/or Gleason 9-10.
Yamazaki H, Suzuki G, Masui K, Aibe N, Shimizu D, Kimoto T, Yamada K, Okihara K, Ueda T, Narukawa T, Shiraishi T, Fujihara A, Yoshida K, Nakamura S, Kato T, Hashimoto Y, Okabe H. Yamazaki H, et al. Among authors: okihara k. Cancers (Basel). 2022 Jun 16;14(12):2976. doi: 10.3390/cancers14122976. Cancers (Basel). 2022. PMID: 35740639 Free PMC article.
122 results